Drug intelligence / Profile preview

3-nitro-4-(2-oxo-pyrrolidin-1-yl)-benzenesulfonamide

Development stage
Preclinical
Modality
Small Molecules
01

Overview

**3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide** is a synthetic small molecule belonging to the phenylpyrrolidine class of organic compounds. It has the molecular formula C10H11N3O5S and a molecular weight of approximately 285.28 g/mol[1][8]. The compound is primarily studied as an experimental inhibitor of carbonic anhydrase enzymes, particularly carbonic anhydrase II, with high potency (IC50 ~0.62 nM)[4][8]. Carbonic anhydrases are zinc-containing enzymes involved in the reversible hydration of carbon dioxide and play roles in pH regulation and ion transport. Inhibition of these enzymes can be relevant for conditions such as glaucoma, epilepsy, edema, and some cancers; however, this compound has not been approved for any clinical use or indication[4]. Its main application remains in biochemical research as a tool compound for studying enzyme inhibition.

Other names
3-nitro-4-(2-oxopyrrolidinyl)benzenesulfonamide3-nitro-4-(2-oxo-pyrrolidinyl)benzene-sulfonamideBenzenesulfonamide, 3-nitro-4-(2‑oxo‑1-pyrrolidinyl)
02

Targets

CA2 (Carbonic Anhydrase 2)

Beyond the preview

Go deeper on 3-nitro-4-(2-oxo-pyrrolidin-1-yl)-benzenesulfonamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-nitro-4-(2-oxo-pyrrolidin-1-yl)-benzenesulfonamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call